Hemophilia is an inherited bleeding disorder that affects the body’s ability to form blood clots properly. Hemophilia A and B are the most common types and are associated with low levels of clotting factor VIII or IX. This Hemophilia Medscape guide explains common symptoms, causes, diagnosis, severity, treatment approaches, inhibitors, and everyday considerations. Understanding how hemophilia affects clotting can help readers recognize important information and discuss appropriate testing and care with qualified healthcare professionals.
Hemophilia is a bleeding disorder in which the blood does not clot normally. The condition is usually inherited and is commonly associated with reduced levels or activity of specific clotting factors. Hemophilia A involves factor VIII deficiency, while hemophilia B involves factor IX deficiency. The severity depends largely on the amount of clotting factor present in the blood.
People with hemophilia may experience prolonged bleeding after injuries, dental procedures, or surgery. Some people, particularly those with more severe disease, can also experience bleeding without an obvious injury. Repeated bleeding into joints can eventually contribute to joint damage and other complications.
How Hemophilia A and B Differ
Hemophilia A and B can have similar symptoms, but they involve different clotting factors. Hemophilia A is caused by low or absent factor VIII, while hemophilia B is associated with low or absent factor IX. Both conditions are commonly inherited through changes in genes located on the X chromosome.
The severity of hemophilia is generally related to clotting factor activity. Lower factor levels can be associated with more frequent or spontaneous bleeding episodes, while people with higher activity levels may experience bleeding mainly after injuries or medical procedures.
Key differences include:
- Hemophilia A involves factor VIII.
- Hemophilia B involves factor IX.
- Both can be inherited within families.
- Severity is related to clotting factor activity.
- Women can also have hemophilia, although it is less common.
- Acquired hemophilia can develop later in life and has different causes from inherited hemophilia.
What Are the Common Symptoms of Hemophilia
Symptoms can vary considerably depending on the severity and type of hemophilia. A person with severe hemophilia may experience bleeding at a younger age, while someone with a milder form may not be diagnosed until later in life.
Common signs can include:
- Bleeding that continues longer than expected after an injury
- Easy or unusual bruising
- Frequent nosebleeds
- Bleeding following dental procedures
- Blood in urine or stool
- Painful or swollen joints caused by internal bleeding
- Unexplained bleeding episodes
- Excessive bleeding following surgery or other procedures
Bleeding into the joints is particularly important because repeated episodes can cause long-term joint problems. Bleeding involving the head or brain can be a serious medical emergency.
How Doctors Diagnose Hemophilia
Diagnosis usually begins with a medical and family history followed by blood testing. Screening tests can indicate whether blood is clotting normally, while specific clotting factor tests can identify the type and severity of hemophilia.
Factor assays are particularly important because they measure the activity of factor VIII and factor IX. These results can help distinguish hemophilia A from hemophilia B and determine the level of clotting factor activity.
A diagnostic evaluation may include:
- Medical and family history
- Physical examination
- Blood clotting screening tests
- Factor VIII and factor IX testing
- Additional testing when an inhibitor is suspected
- Genetic testing in appropriate situations
Families with a history of hemophilia may discuss testing options with a healthcare professional, particularly during pregnancy or after the birth of a child.
How Hemophilia Is Treated
Treatment depends on the type and severity of hemophilia, bleeding history, age, overall health, and other individual factors. The traditional approach for hemophilia A and B involves replacing the missing clotting factor. Factor concentrates can be administered to stop bleeding or used regularly to help prevent bleeding episodes.
Some people with hemophilia A may also receive non-factor therapy. For example, emicizumab works by helping replace the function of factor VIII and can be used to reduce bleeding episodes in people with hemophilia A. Other approaches, such as desmopressin, may be appropriate for certain people with mild hemophilia A.
Treatment approaches may include:
- Factor VIII replacement for hemophilia A
- Factor IX replacement for hemophilia B
- Preventive treatment known as prophylaxis
- Treatment given when a bleeding episode occurs
- Non-factor therapy for selected people with hemophilia A
- Desmopressin for certain mild cases
- Gene therapy for selected adults with particular types of hemophilia
The appropriate treatment should be determined by a qualified healthcare professional familiar with bleeding disorders.
Why Hemophilia Inhibitors Matter
Some people with hemophilia develop antibodies called inhibitors. These antibodies can interfere with clotting factor treatment and make bleeding episodes more difficult to control.
According to the CDC, inhibitors develop in approximately 1 in 5 people with hemophilia A and around 3 in 100 people with hemophilia B. Regular testing can help identify inhibitors, and specialized treatment may be required when they occur.
Important points about inhibitors include:
- They can reduce the effectiveness of factor treatment.
- Blood tests can identify inhibitors.
- Inhibitor levels can be measured using specialized laboratory testing.
- Some people require alternative approaches to manage bleeding.
- Regular monitoring can help identify inhibitors earlier.
Because inhibitor management can be complex, people with known or suspected inhibitors may require specialized care from healthcare professionals experienced in bleeding disorders.
Hemophilia Medscape Insights at a Glance
| Topic | Key Insight |
|---|---|
| Hemophilia A | Associated with low or absent factor VIII |
| Hemophilia B | Associated with low or absent factor IX |
| Main symptom | Abnormal or prolonged bleeding |
| Diagnosis | Blood tests and clotting factor assays |
| Severity | Related to clotting factor activity |
| Common complication | Repeated bleeding into joints |
| Treatment approach | Factor replacement or other appropriate therapies |
| Inhibitors | Antibodies that can interfere with factor treatment |
| Prevention | Regular preventive treatment may reduce bleeding episodes |
| Specialist care | Bleeding disorder centers can provide comprehensive support |
Tips for Understanding Hemophilia
Learning how hemophilia works can make medical information easier to understand. Keeping a record of bleeding episodes, treatments, laboratory results, and relevant family history can also provide useful information during healthcare appointments.
People living with hemophilia should discuss planned surgeries, dental procedures, injuries, and unusual bleeding with their healthcare team. Treatment plans can vary significantly between individuals, so information intended for the general public should not replace personalized medical advice.
Conclusion
Hemophilia is a lifelong bleeding disorder that can be managed with appropriate medical care and monitoring. Hemophilia A and B are the most common forms and involve deficiencies of factor VIII and factor IX respectively. Modern treatment approaches include clotting factor replacement, preventive therapy, selected non-factor treatments, and newer options such as gene therapy for certain patients.
Understanding symptoms, diagnosis, treatment approaches, and inhibitors can help people make sense of reliable hemophilia information. Anyone experiencing unusual or severe bleeding should seek prompt medical evaluation, particularly when bleeding involves the head, brain, or another potentially serious area.